- Indicated treatments
-
Removing lesions comprising atheroma, fibrosis, calcium, and neointimal hyperplasia in the coronary and peripheral vasculature, and transvenous removal of problematic pacing and defibrillator leads.
Removing lesions comprising atheroma, fibrosis, calcium, and neointimal hyperplasia in the coronary and peripheral vasculature, and transvenous removal of problematic pacing and defibrillator leads. - Proven excimer technology
-
Cool, ultraviolet laser with over 20 years of clinical experience. More than 600,000 procedures performed. The only atherectomy device with level 1 clinical evidence proven for safety and efficacy in ISR.¹
Cool, ultraviolet laser with over 20 years of clinical experience. More than 600,000 procedures performed. The only atherectomy device with level 1 clinical evidence proven for safety and efficacy in ISR.¹ - Versatile: more vessels, more indications
-
For use in any lab, on any floor. Philips Laser System supports indications in CV and PV and is among the only laser systems available for lead management procedures.² Control of both fluence and rate is in the physician’s hands for individualised treatment of each patient.
For use in any lab, on any floor. Philips Laser System supports indications in CV and PV and is among the only laser systems available for lead management procedures.² Control of both fluence and rate is in the physician’s hands for individualised treatment of each patient. - Simple: Turn-key in any room
-
Touchscreen guided workflows and minimal warm-up time improve system availability when it is needed. 360° maneuverability and a small lab footprint enables easy positioning within any lab, where it is needed.
Touchscreen guided workflows and minimal warm-up time improve system availability when it is needed. 360° maneuverability and a small lab footprint enables easy positioning within any lab, where it is needed.
Removing lesions comprising atheroma, fibrosis, calcium, and neointimal hyperplasia in the coronary and peripheral vasculature, and transvenous removal of problematic pacing and defibrillator leads.
Removing lesions comprising atheroma, fibrosis, calcium, and neointimal hyperplasia in the coronary and peripheral vasculature, and transvenous removal of problematic pacing and defibrillator leads.
Removing lesions comprising atheroma, fibrosis, calcium, and neointimal hyperplasia in the coronary and peripheral vasculature, and transvenous removal of problematic pacing and defibrillator leads.
Cool, ultraviolet laser with over 20 years of clinical experience. More than 600,000 procedures performed. The only atherectomy device with level 1 clinical evidence proven for safety and efficacy in ISR.¹
Cool, ultraviolet laser with over 20 years of clinical experience. More than 600,000 procedures performed. The only atherectomy device with level 1 clinical evidence proven for safety and efficacy in ISR.¹
Cool, ultraviolet laser with over 20 years of clinical experience. More than 600,000 procedures performed. The only atherectomy device with level 1 clinical evidence proven for safety and efficacy in ISR.¹
For use in any lab, on any floor. Philips Laser System supports indications in CV and PV and is among the only laser systems available for lead management procedures.² Control of both fluence and rate is in the physician’s hands for individualised treatment of each patient.
For use in any lab, on any floor. Philips Laser System supports indications in CV and PV and is among the only laser systems available for lead management procedures.² Control of both fluence and rate is in the physician’s hands for individualised treatment of each patient.
For use in any lab, on any floor. Philips Laser System supports indications in CV and PV and is among the only laser systems available for lead management procedures.² Control of both fluence and rate is in the physician’s hands for individualised treatment of each patient.
Touchscreen guided workflows and minimal warm-up time improve system availability when it is needed. 360° maneuverability and a small lab footprint enables easy positioning within any lab, where it is needed.
Touchscreen guided workflows and minimal warm-up time improve system availability when it is needed. 360° maneuverability and a small lab footprint enables easy positioning within any lab, where it is needed.
Touchscreen guided workflows and minimal warm-up time improve system availability when it is needed. 360° maneuverability and a small lab footprint enables easy positioning within any lab, where it is needed.
- Indicated treatments
- Proven excimer technology
- Versatile: more vessels, more indications
- Simple: Turn-key in any room
- Indicated treatments
-
Removing lesions comprising atheroma, fibrosis, calcium, and neointimal hyperplasia in the coronary and peripheral vasculature, and transvenous removal of problematic pacing and defibrillator leads.
Removing lesions comprising atheroma, fibrosis, calcium, and neointimal hyperplasia in the coronary and peripheral vasculature, and transvenous removal of problematic pacing and defibrillator leads. - Proven excimer technology
-
Cool, ultraviolet laser with over 20 years of clinical experience. More than 600,000 procedures performed. The only atherectomy device with level 1 clinical evidence proven for safety and efficacy in ISR.¹
Cool, ultraviolet laser with over 20 years of clinical experience. More than 600,000 procedures performed. The only atherectomy device with level 1 clinical evidence proven for safety and efficacy in ISR.¹ - Versatile: more vessels, more indications
-
For use in any lab, on any floor. Philips Laser System supports indications in CV and PV and is among the only laser systems available for lead management procedures.² Control of both fluence and rate is in the physician’s hands for individualised treatment of each patient.
For use in any lab, on any floor. Philips Laser System supports indications in CV and PV and is among the only laser systems available for lead management procedures.² Control of both fluence and rate is in the physician’s hands for individualised treatment of each patient. - Simple: Turn-key in any room
-
Touchscreen guided workflows and minimal warm-up time improve system availability when it is needed. 360° maneuverability and a small lab footprint enables easy positioning within any lab, where it is needed.
Touchscreen guided workflows and minimal warm-up time improve system availability when it is needed. 360° maneuverability and a small lab footprint enables easy positioning within any lab, where it is needed.
Removing lesions comprising atheroma, fibrosis, calcium, and neointimal hyperplasia in the coronary and peripheral vasculature, and transvenous removal of problematic pacing and defibrillator leads.
Removing lesions comprising atheroma, fibrosis, calcium, and neointimal hyperplasia in the coronary and peripheral vasculature, and transvenous removal of problematic pacing and defibrillator leads.
Removing lesions comprising atheroma, fibrosis, calcium, and neointimal hyperplasia in the coronary and peripheral vasculature, and transvenous removal of problematic pacing and defibrillator leads.
Cool, ultraviolet laser with over 20 years of clinical experience. More than 600,000 procedures performed. The only atherectomy device with level 1 clinical evidence proven for safety and efficacy in ISR.¹
Cool, ultraviolet laser with over 20 years of clinical experience. More than 600,000 procedures performed. The only atherectomy device with level 1 clinical evidence proven for safety and efficacy in ISR.¹
Cool, ultraviolet laser with over 20 years of clinical experience. More than 600,000 procedures performed. The only atherectomy device with level 1 clinical evidence proven for safety and efficacy in ISR.¹
For use in any lab, on any floor. Philips Laser System supports indications in CV and PV and is among the only laser systems available for lead management procedures.² Control of both fluence and rate is in the physician’s hands for individualised treatment of each patient.
For use in any lab, on any floor. Philips Laser System supports indications in CV and PV and is among the only laser systems available for lead management procedures.² Control of both fluence and rate is in the physician’s hands for individualised treatment of each patient.
For use in any lab, on any floor. Philips Laser System supports indications in CV and PV and is among the only laser systems available for lead management procedures.² Control of both fluence and rate is in the physician’s hands for individualised treatment of each patient.
Touchscreen guided workflows and minimal warm-up time improve system availability when it is needed. 360° maneuverability and a small lab footprint enables easy positioning within any lab, where it is needed.
Touchscreen guided workflows and minimal warm-up time improve system availability when it is needed. 360° maneuverability and a small lab footprint enables easy positioning within any lab, where it is needed.
Touchscreen guided workflows and minimal warm-up time improve system availability when it is needed. 360° maneuverability and a small lab footprint enables easy positioning within any lab, where it is needed.
Specifications
- System specifications
-
System specifications Active medium - XeCl
Weight - 480 lbs / 217 kg
Wavelength - 308 nm
Length - 52 in / 132 cm
Catheter output fluence - 30-80 mJ/mm2
Height - 42 in / 107 cm
Repetition rate - 25-80 Hz
Width - 19 in / 48 cm
Pulse width - 125-200 ns, FWHM
-
- System specifications
-
System specifications Active medium - XeCl
Weight - 480 lbs / 217 kg
-
- System specifications
-
System specifications Active medium - XeCl
Weight - 480 lbs / 217 kg
Wavelength - 308 nm
Length - 52 in / 132 cm
Catheter output fluence - 30-80 mJ/mm2
Height - 42 in / 107 cm
Repetition rate - 25-80 Hz
Width - 19 in / 48 cm
Pulse width - 125-200 ns, FWHM
-
Related products
Alternative products
-
Turbo-Power
- Uniquely designed to optimize ISR treatment
- Treats at the tip with eccentric vaporizing technology for maximal luminal gain
- Debulks the lesion in a single step
- Remote automatic rotation for precise directional control
View product
-
GlideLight
- Safely and efficiently remove leads
- Customise the laser's repetition rate throughout procedure
- Use up to 55% less advancement force¹
- Advance up to 62% more efficiently²
View product
-
Turbo-Elite
- Treats multiple lesion morphologies within PAD lesions
- Works at the molecular level through three unique mechanisms of action
- Capable of powering through the most challenging restenoses and occlusions
- Provides the precision and control required to preserve vessels and save limbs
View product
-
ELCA
- Adjustable laser energy settings
- Automatic shut-off feature
View product
-
Turbo-Power
The Turbo-Power laser atherectomy catheter debulks the lesion in a single step and offers remote automatic rotation for precise directional control. Turbo-Power is the only atherectomy device proven and approved for the treat of ISR.
View product
-
GlideLight
Safely and efficiently removing leads depends on tools that give you versatility and control. GlideLight laser sheath offers the unprecedented ability to customise the laser’s repetition rate throughout a procedure. At 80Hz, the GlideLight laser sheath requires up to 55% less advancement force,¹ and advance up to 62% more efficiently through tough binding sites than SLS II.²
View product
-
Turbo-Elite
Turbo-Elite laser atherectomy catheter captures the power of ultraviolet light to provide a versatile and reliable tool for treating multiple lesion morphologies within PAD lesions. Utilising laser's unique mechanism of action, Turbo-Elite is capable of powering through the most challenging restenosis and occlusions.
View product
See all related products
- 1. Internal Sales data on file.
- 2. Dippel et al. Randomized Controlled Study of Excimer Laser Atherectomy for Treatment of Femoropopliteal In-stent Restenosis: Initial ISR Results (2015). JACC 8(1): 92-101.
- Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
- <b>Philips Laser System Important Safety Information</b> The Philips Laser system is used in minimally invasive interventional procedures within the cardiovascular system and for the removal of problematic pacemaker and defibrillator cardiac leads. The Philips Laser System produces pulsed excimer radiation, which is delivered to the target site with proprietary fiber optic catheter technology, or other approved instruments or accessories, to complete the system. For information on indications, contraindications, adverse events, and other important safety information, refer to the individual instructions for use that accompanies the Philips fiber-optic catheters. <b>Important</b> Read the Operator's Manual thoroughly before operating the system. Pay particular attention to the notes, cautions, and warnings throughout the manual to ensure safe operating conditions at all times. Also, refer to the Instructions for Use that accompanies the Philips fiber-optic catheters. Indications and contraindications are included in the individual instructions for use for the catheters.
- <b>Warnings</b> • The Philips Laser System contains a Class IV laser that produces an invisible beam of high-energy ultraviolet radiation. Improper use of the system could result in serious personal injury. Observe all safety precautions for use of Class IV laser equipment. • The system contains high voltages, which are potentially lethal. To avoid electrical shock, do not open the system cabinet. external maintenance must be performed solely by a certified field service engineer. • The system is not intended to be used during a defibrillation event. • Skin exposure to excimer radiation should be avoided • Possible explosion hazard if used in the presence of flammable anesthetics. <b>Notice</b> • The system is intended for use only by licensed physicians. All persons who operate and service the system must be properly trained. • The system contains a gas mixture that is 0.05% HCl, a respiratory irritant. To avoid injury, only a trained and certified field service engineer should handle the laser gas.
- <b>Safety Precautions</b> • The laser system must be operated only by trained personnel. • Always wear safety glasses with an Optical Density ≥9 @ 308nM for eye protection against laser radiation. • Establish a controlled-access laser operating area to limit access to persons Instructed in the safe operation of lasers. • Post "Laser in operation" warning signs at all entries to the laser operating area. • Persons in the laser operating area including doctors, nurses, observers and the patient must wear the appropriate protective eyewear and protective gloves. • Never look directly into the laser beam. • Avoid uncontrolled reflections of the laser beam. • Skin exposure to excimer laser radiation should be avoided. • Do not allow direct or reflected laser radiation to go beyond the laser operating area. • When not in use, the laser system should be protected against unauthorized use by removing the key. • Special precautions are required regarding the Electromagnetic Compatibility (EMC) of the Philips Laser System. Refer to the user manual for details. • Caution: Federal law restricts this device to sale by or on the order of a physician.
- <b>ELCA Important Safety Information</b> The Laser Catheters used in conjunction with the Philips CVX-300 Excimer Laser System are intended for use in patients with single or multivessel coronary artery disease, either as a stand-alone modality or in conjunction with Percutaneous Transluminal Coronary Balloon Angioplasty (PTCA), and who are acceptable candidates for coronary artery bypass graft (CABG) surgery. Adjunctive balloon angioplasty was performed, at the clinical investigator’s discretion, for 85% of the lesions treated. The following Indications for Use, Contraindications and Warnings have been established through multicenter clinical trials. Clinical experience has provided reasonable assurance that the Philips CVX-300 Excimer Laser System and the multifiber laser catheter models are safe and effective for the following indications:
- • Occluded saphenous vein bypass grafts • Ostial lesions • Long lesions (greater than 20mm in length) • Moderately calcified stenoses (Heavily calcified stenoses are those lesions that demonstrate complete calcification when identified under fluoroscopy by angiography prior to the procedure. Moderately and slightly calcified stenoses are all others.) • Total occlusions traversable by a guidewire • Lesions which previously failed balloon angioplasty (This includes those lesions that were treated unsuccessfully by PTCA. Lesions that have undergone a complicated PTCA procedure are not included in this category.) • Restenosis in 316L stainless steel stents, prior to the administration of intravascular brachytherapy. (not indicated for X-80 models) These lesions must be traversable by a guidewire and composed of atherosclerotic plaque and/or calcified material. The lesions should be well defined by angiography
- <b>Contraindictations</b> • Lesion is in an unprotected left main artery • Lesion is beyond acute bends or is in a location within the coronary anatomy where the catheter cannot traverse • Guidewire cannot be passed through the lesion • Lesion is located within a bifurcation • Patient is not an acceptable candidate for bypass graft surgery • Patient has acute thrombosis (applicable to X-80 models only) • Patient has experienced an acute myocardial infarction (applicable to X-80 models only) • Patient has ejection fraction of less than 30% (applicable to X-80 models only) See complete IFU for more information before attempting use of ELCA. <b>Potential adverse events</b> • Use of ELCA may contribute to the following complications: dissection of the arterial wall, perforation, acute reclosure, embolization, aneurysm formation, spasm, coronary artery bypass graft surgery, thrombus, myocardial infarction, arrhythmia, filling defects, death. • No long-term adverse effects of ELCA are known at this time.
- <b>GlideLight Important Safety Information</b> <b>Indications for Use</b> The Laser Sheath is intended for use as an adjunct to conventional lead extraction tools in patients suitable for transvenous removal of chronically implanted pacing or defibrillator leads constructed with silicone or polyurethane outer insulation. <b>Contraindications</b> Use of the Laser Sheath is contraindicated: • When emergency thoracotomy with cardiopulmonary bypass cannot be performed immediately in the event of a life threatening complication; • When fluoroscopy is not available; • In patients in whom superior venous approach cannot be used; • When the proximal end of the pacing lead is not accessible to the operator; • When the lead will not fit into the inner lumen of the Laser Sheath. <b>Potential Adverse Events</b> The following adverse events or conditions may also occur during lead extraction with the Laser Sheath, but were not observed during the clinical study (listed in alphabetical order): bacteremia, low cardiac output, migration of lead fragments, migration of vegetation, myocardial avulsion/perforation, premature ventricular contractions, pulmonary embolism, stroke, venous avulsion/perforation, ventricular tachycardia. Caution: Federal law restricts this device to sale by or on the order of a physician.
